vs

Side-by-side financial comparison of Canaan Inc. (CAN) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.

SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $20.8M, roughly 1.9× Canaan Inc.). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -18.4%, a 54.3% gap on every dollar of revenue.

Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.

SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.

CAN vs SBC — Head-to-Head

Bigger by revenue
SBC
SBC
1.9× larger
SBC
$39.6M
$20.8M
CAN
Higher net margin
SBC
SBC
54.3% more per $
SBC
35.9%
-18.4%
CAN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CAN
CAN
SBC
SBC
Revenue
$20.8M
$39.6M
Net Profit
$-3.8M
$14.2M
Gross Margin
99.9%
73.1%
Operating Margin
-15.9%
32.5%
Net Margin
-18.4%
35.9%
Revenue YoY
-10.9%
Net Profit YoY
117.2%
EPS (diluted)
$-0.05
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAN
CAN
SBC
SBC
Q4 25
$20.8M
$39.6M
Q3 25
$13.8M
$43.4M
Q2 25
$11.4M
$43.4M
Q1 25
$47.3M
Q4 24
$44.4M
Q3 24
$10.2M
$53.1M
Q2 24
$4.8M
$53.1M
Q1 24
$54.8M
Net Profit
CAN
CAN
SBC
SBC
Q4 25
$-3.8M
$14.2M
Q3 25
$-1.5M
$12.8M
Q2 25
$-11.9M
$2.5M
Q1 25
$21.5M
Q4 24
$6.5M
Q3 24
$-10.4M
$2.8M
Q2 24
$-5.4M
$18.5M
Q1 24
$18.8M
Gross Margin
CAN
CAN
SBC
SBC
Q4 25
99.9%
73.1%
Q3 25
99.9%
70.6%
Q2 25
99.9%
69.2%
Q1 25
79.7%
Q4 24
76.3%
Q3 24
99.9%
81.5%
Q2 24
99.8%
74.2%
Q1 24
72.1%
Operating Margin
CAN
CAN
SBC
SBC
Q4 25
-15.9%
32.5%
Q3 25
-27.0%
36.6%
Q2 25
-45.5%
33.6%
Q1 25
51.1%
Q4 24
10.6%
Q3 24
-77.2%
26.1%
Q2 24
-193.9%
51.4%
Q1 24
44.6%
Net Margin
CAN
CAN
SBC
SBC
Q4 25
-18.4%
35.9%
Q3 25
-11.0%
29.6%
Q2 25
-104.4%
5.7%
Q1 25
45.4%
Q4 24
14.7%
Q3 24
-102.7%
5.3%
Q2 24
-112.3%
34.8%
Q1 24
34.2%
EPS (diluted)
CAN
CAN
SBC
SBC
Q4 25
$-0.05
$0.15
Q3 25
$-0.02
$0.12
Q2 25
$-0.25
$0.02
Q1 25
$0.21
Q4 24
$0.05
Q3 24
$0.03
Q2 24
$0.20
Q1 24
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAN
CAN
SBC
SBC
Cash + ST InvestmentsLiquidity on hand
$164.1M
Total DebtLower is stronger
$6.2M
$42.8M
Stockholders' EquityBook value
$52.4M
$248.3M
Total Assets
$92.5M
$380.4M
Debt / EquityLower = less leverage
0.12×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAN
CAN
SBC
SBC
Q4 25
$164.1M
Q3 25
$127.4M
Q2 25
$152.7M
Q1 25
$132.1M
Q4 24
$125.0M
Q3 24
$137.4M
Q2 24
Q1 24
Total Debt
CAN
CAN
SBC
SBC
Q4 25
$6.2M
$42.8M
Q3 25
$6.2M
$21.1M
Q2 25
$6.2M
$7.1M
Q1 25
$6.9M
Q4 24
$6.6M
Q3 24
$823.2K
Q2 24
Q1 24
Stockholders' Equity
CAN
CAN
SBC
SBC
Q4 25
$52.4M
$248.3M
Q3 25
$44.7M
$248.0M
Q2 25
$33.8M
$244.6M
Q1 25
$226.4M
Q4 24
$195.1M
Q3 24
$43.6M
$205.0M
Q2 24
$56.8M
$8.8M
Q1 24
$9.0M
Total Assets
CAN
CAN
SBC
SBC
Q4 25
$92.5M
$380.4M
Q3 25
$81.7M
$321.4M
Q2 25
$78.0M
$315.3M
Q1 25
$284.6M
Q4 24
$266.1M
Q3 24
$69.3M
$296.5M
Q2 24
$73.7M
$19.5M
Q1 24
$19.8M
Debt / Equity
CAN
CAN
SBC
SBC
Q4 25
0.12×
0.17×
Q3 25
0.14×
0.09×
Q2 25
0.18×
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.00×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAN
CAN
SBC
SBC
Operating Cash FlowLast quarter
$52.0M
Free Cash FlowOCF − Capex
$51.2M
FCF MarginFCF / Revenue
129.3%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
3.66×
TTM Free Cash FlowTrailing 4 quarters
$23.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAN
CAN
SBC
SBC
Q4 25
$52.0M
Q3 25
$-20.9M
Q2 25
$-8.3M
Q1 25
$1.9M
Q4 24
$-7.3M
Q3 24
$5.0M
Q2 24
$19.2M
Q1 24
$3.7M
Free Cash Flow
CAN
CAN
SBC
SBC
Q4 25
$51.2M
Q3 25
$-20.9M
Q2 25
$-8.6M
Q1 25
$1.7M
Q4 24
$-7.9M
Q3 24
$4.6M
Q2 24
$18.3M
Q1 24
$3.0M
FCF Margin
CAN
CAN
SBC
SBC
Q4 25
129.3%
Q3 25
-48.3%
Q2 25
-19.9%
Q1 25
3.5%
Q4 24
-17.8%
Q3 24
8.7%
Q2 24
34.5%
Q1 24
5.4%
Capex Intensity
CAN
CAN
SBC
SBC
Q4 25
2.0%
Q3 25
0.1%
Q2 25
0.7%
Q1 25
0.5%
Q4 24
1.3%
Q3 24
0.8%
Q2 24
1.6%
Q1 24
1.3%
Cash Conversion
CAN
CAN
SBC
SBC
Q4 25
3.66×
Q3 25
-1.63×
Q2 25
-3.39×
Q1 25
0.09×
Q4 24
-1.12×
Q3 24
1.77×
Q2 24
1.04×
Q1 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAN
CAN

Segment breakdown not available.

SBC
SBC

Franchising$10.3M26%
Medical Corporation Shobikai$8.1M21%
Medical Corporation Nasukai$7.2M18%
Management Services$6.3M16%
Rental Services$4.3M11%
Medical Corporation Association Furinkai$3.0M8%
Japan Medical And Beauty Inc$656.5K2%

Related Comparisons